Zenagamtide
A Research Study Looking at the Effect of Timing of Meal After Dosing and Water Volume at Dosing on How the Medicine Zenagamtide is Taken up by the Body of Participants With Overwe
Novo Nordisk · Phase 1 · Recruiting · Enrollment 320
Participants reaching threshold, %
Source: Cited trial source. The denominator is the source figure, when it states one.
No selected arm reports a responder percent.
Show as table
| Arm | ≥5% | ≥10% | ≥15% | ≥20% |
|---|---|---|---|---|
| Zenagamtide subcutaneous (s.c.) | n/r | n/r | n/r | n/r |
| Zenagamtide oral | n/r | n/r | n/r | n/r |
Not shown
- Zenagamtide subcutaneous (s.c.): endpoint not reported
- Zenagamtide oral: endpoint not reported